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Otologic opioid usage and pain control in the postoperative period 
 Matthew Stewart BS, Eric Mastrolonardo BS, Joann Butkus BS, Raphael Banoub MD, 
Tingting Zhan PhD, Sophia Dang MD, David Cognetti MD, Rebecca Chiffer MD*, Thomas 
Willcox MD 
(*) indicates primary project advisor 
Introduction: Patients’ unused prescription opioids can be diverted and increase the overall 
opioid burden on society. Therefore, otolaryngologists can reduce opioid influx by minimizing 
excess tablets in opioid prescriptions. We hypothesize that otology patients at TJUH receive 
more opioid tablets than needed to effectively manage postoperative pain. 
Methods: Patients ages ≥18 years old who received otologic surgery at TJUH were included in 
this prospective observational study between November 2019 and August 2020. Patients were 
provided a survey for recording pain on postoperative days 0, 1, 3, and 7 and the amount of 
remaining opioids from their prescription. Opioid amounts were converted to morphine 
milligram equivalents (MME) for analysis. Mean and standard deviation were calculated for pain 
scores, MME prescribed, and MME used. A multivariate regression model was used to predict 
increased MME usage for selected indicators. 
Results: Ninety-one patients completed the study. Collectively, forty-seven percent of MME 
were unused, while seventy percent of MME were unused in patients receiving a transcanal 
incision (n=28/91). Pain scores and MME utilization differed significantly between transcanal 
and postauricular cohorts (p=0.002). Additionally, patients with a postauricular incision had 60% 
more opioid usage (p<0.001). Low pain scores and high proportions of unused MME in 
stapedectomy and transcanal tympanoplasty indicate that postoperative pain in these procedures 
may be managed with reduced opioid prescriptions and/or NSAIDs.  
Discussion: A significant amount of opioids were unused in this study. Patients with 
postauricular incisions had significantly increased opioid utilization than patients with transcanal 
incisions. These results support the hypothesis that otologic patients are overprescribed 
postoperative opioids. Otologists may be able to manage postoperative pain with reduced opioid 
prescriptions, multimodal analgesia, and increased patient education. This can be leveraged as a 
point of intervention in the opioid epidemic to reduce excess opioids in the community. 
